» Articles » PMID: 38106549

Development and Material Characteristics of Glaucoma Surgical Implants

Overview
Specialty Ophthalmology
Date 2023 Dec 18
PMID 38106549
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Glaucoma is the leading cause of irreversible blindness worldwide. The reduction of intraocular pressure has proved to be the only factor which can be modified in the treatment, and surgical management is one of the important methods for the treatment of glaucoma patients.

Main Text: In order to increase aqueous humor outflow and further reduce intraocular pressure, various drainage implants have been designed and applied in clinical practice. From initial Molteno, Baerveldt and Ahmed glaucoma implants to the Ahmed ClearPath device, Paul glaucoma implant, EX-PRESS and the eyeWatch implant, to iStent, Hydrus, XEN, PreserFlo, Cypass, SOLX Gold Shunt, etc., glaucoma surgical implants are currently undergoing a massive transformation on their structures and performances. Multitudinous materials have been used to produce these implants, from original silicone and porous polyethylene, to gelatin, stainless steel, SIBS, titanium, nitinol and even 24-carat gold. Moreover, the material geometry, size, rigidity, biocompatibility and mechanism (valved versus nonvalved) among these implants are markedly different. In this review, we discussed the development and material characteristics of both conventional glaucoma drainage devices and more recent implants, such as the eyeWatch and the new minimally invasive glaucoma surgery (MIGS) devices.

Conclusions: Although different in design and materials, these delicate glaucoma surgical implants have widely expanded the glaucoma surgical methods, and improved the success rate and safety of glaucoma surgery significantly. However, all of these glaucoma surgical implants have various limitations and should be used for different glaucoma patients at different conditions.

Citing Articles

Management of fracture and displacement of a previously successful bilateral transconjunctival ab-externo XEN gel stent: a case report.

Zhang Q, Zhang C, Liu X, Chen M, Wang K BMC Ophthalmol. 2025; 25(1):98.

PMID: 40016691 PMC: 11869487. DOI: 10.1186/s12886-025-03922-2.


In Vitro Analysis of Pressure Resistance in the Paul Glaucoma Implant and Ahmed ClearPath 250 With and Without Polypropylene Thread Inside the Tube.

Masdipa A, Kaidzu S, Tanito M Transl Vis Sci Technol. 2025; 14(1):2.

PMID: 39774608 PMC: 11717134. DOI: 10.1167/tvst.14.1.2.


Efficacy and safety of the paul glaucoma implant in the treatment of refractory primary congenital glaucoma.

Karapapak M, Olgun A Jpn J Ophthalmol. 2024; 68(5):571-577.

PMID: 38935223 PMC: 11420279. DOI: 10.1007/s10384-024-01076-0.


γ-Cyclodextrin hydrogel for the sustained release of josamycin for potential ocular application.

Huling J, Oschatz S, Lange H, Sterenczak K, Stahnke T, Markhoff J Drug Deliv. 2024; 31(1):2361168.

PMID: 38899440 PMC: 11191840. DOI: 10.1080/10717544.2024.2361168.


Paul Glaucoma Implant following Congenital Cataract Surgery in a Pediatric Cohort.

Mendoza-Moreira A, Voigt A, Stingl J, Rezapour J, Wagner F, Schuster A J Clin Med. 2024; 13(10).

PMID: 38792454 PMC: 11122222. DOI: 10.3390/jcm13102914.

References
1.
Jacob J, Burgoyne C, McKinnon S, Tanji T, LaFleur P, Duzman E . Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res. 1998; 43(2):99-107. DOI: 10.1002/(sici)1097-4636(199822)43:2<99::aid-jbm3>3.0.co;2-g. View

2.
Vernazza S, Oddone F, Tirendi S, Bassi A . Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention. Int J Mol Sci. 2021; 22(15). PMC: 8346985. DOI: 10.3390/ijms22157994. View

3.
Pinchuk L . The Development of a SIBS Shunt to Treat Glaucoma. J Ocul Pharmacol Ther. 2023; 39(8):530-540. DOI: 10.1089/jop.2023.0005. View

4.
Tseng V, Coleman A, Chang M, Caprioli J . Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017; 7:CD004918. PMC: 5580949. DOI: 10.1002/14651858.CD004918.pub3. View

5.
Gonzalez-Rodriguez J, Trope G, Drori-Wagschal L, Jinapriya D, Buys Y . Comparison of trabeculectomy versus Ex-PRESS: 3-year follow-up. Br J Ophthalmol. 2015; 100(9):1269-73. DOI: 10.1136/bjophthalmol-2015-307161. View